focus -WSS

focus

author：comprehensive 2025-09-30 16:24:57 - browse：598

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： PhRMA sues HHS over Medicare drug price negotiation

WSS

These geoengineering technologies could help combat the climate crisis, scientists say

Dario to buy mental health app maker Twill in cash and stock deal

Listen: Biogen's messy board & Laronde's data problem

A new study asks: Are we harming blood donors by taking blood?

Brain 'hot spot' may explain why African Americans feel greater pain

R1 RCM gets $5.8 billion buyout offer from private equity firm

hotspot

focus

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Alabama frozen embryo ruling has major implications for IVF clinics

Sports medicine is finally prioritizing gender equality

Medicare inequities exacerbate Puerto Rico’s health disparities

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Virginia high school admissions case could be legal follow

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Malaria cases in Florida and Texas: Here’s what you need to know

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

hotspot

Grail is spending more than ever lobbying Congress

Obesity drugs seen as possible treatment for liver disease MASH

Inside the fall of star MIT scientist David Sabatini

Listen: Biogen's messy board & Laronde's data problem

Did the public have the right to know Arthur Ashe had AIDS?

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Wikipedia

hotspot

Wikipedia

Wikipedia